Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson, Halfdan Sorbye, Staffan Welin, Birgitte Federspiel, Henning Gronbaek, Per Hellman, Morten Ladekarl, Seppo W. Langer, Jann Mortensen, Camilla Schalin-Jantti, Anders Sundin, Anna Sundlöv, Espen Thiis-Evensen, Ulrich Knigge

Research output: Contribution to journalReview articlepeer-review

Abstract

Background. The diagnostic work-up and treatment of patients with neuroendocrine neoplasms (NENs) has undergone major recent advances and new methods are currently introduced into the clinic. An update of the WHO classification has resulted in a new nomenclature dividing NENs into neuroendocrine tumours (NETs) including G1 (Ki67 index <= 2%) and G2 (Ki67 index 3-20%) tumours and neuroendocrine carcinomas (NECs) with Ki67 index > 20%, G3. Aim. These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients.
Original languageEnglish
Pages (from-to)1284-1297
JournalActa Oncologica
Volume53
Issue number10
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Cancer and Oncology

Fingerprint

Dive into the research topics of 'Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms'. Together they form a unique fingerprint.

Cite this